Accuray Incorporated (ARAY)
After hours: 04:00PM EDT
Chart Events
Performance Outlook
| Previous Close | 4.2900 |
| Open | 4.3000 |
| Bid | 4.3800 x 3000 |
| Ask | 5.0000 x 4000 |
| Day's Range | 4.2706 - 4.4850 |
| 52 Week Range | 1.9600 - 6.0200 |
| Volume | 535,754 |
| Avg. Volume | 778,450 |
| Market Cap | 414.078M |
| Beta (5Y Monthly) | 1.94 |
| PE Ratio (TTM) | 88.80 |
| EPS (TTM) | 0.0500 |
| Earnings Date | Aug 11, 2021 - Aug 16, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.25 |
- Zacks
Accuray's (ARAY) CyberKnife Gets Support From RayStation TPS
Accuray (ARAY) introduces RayStation treatment planning support for CyberKnife Radiotherapy System and other radiation therapy devices.
- PR Newswire
Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System
Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the company's CyberKnife® M6™** and S7™** Robotic, Radiotherapy Systems. RayStation helps enable clinicians to create treatment plans for the CyberKnife M6 and S7 Systems and other conventional radiation therapy devices in one unified treatment planning system (TPS), making it easier to integrate the Accuray systems within the radiation oncology department. Integration will help to improv
- Zacks
Accuray (ARAY) Expands Commercialization of CE-Marked ClearRT
Accuray's (ARAY) ClearRT imaging capability, which is now widely available following receipt of the CE Mark, offers better precision and accuracy in radiation therapy.
